COMMUNIQUÉS West-GlobeNewswire

Pliant Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

12/06/2024 - 22:05

SOUTH SAN FRANCISCO, Calif., June 12, 2024 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX), today announced that on June 10, 2024, it granted stock options to purchase an aggregate of 120,000 shares of [...]

Ultragenyx Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

12/06/2024 - 22:05

NOVATO, Calif., June 12, 2024 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for serious rare and [...]

Cara Therapeutics Announces Outcome of Part A of KOURAGE-1 Study Evaluating Oral Difelikefalin in Notalgia Paresthetica

12/06/2024 - 22:01

– Oral difelikefalin did not demonstrate meaningful clinical benefit compared to placebo – – Company will discontinue clinical program in NP and explore strategic alternatives – STAMFORD, Conn., June 12, 2024 (GLOBE [...]

Barinthus Bio Announces Strategic Pipeline Prioritization Following Positive Interim Data from VTP-300 in Chronic Hepatitis B Virus Infections

12/06/2024 - 22:01

The development of VTP-300 in chronic Hepatitis B (CHB) and VTP-1000 in celiac disease will be prioritized. The pipeline prioritization is expected to result in a reduction in workforce of approximately 25% and an [...]

Rapport Therapeutics Announces Closing of $174 Million Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares and Concurrent Private Placement

12/06/2024 - 22:01

BOSTON and SAN DIEGO, June 12, 2024 (GLOBE NEWSWIRE) -- Rapport Therapeutics, Inc. (Nasdaq: RAPP), a clinical-stage biotechnology company focused on discovery and development of transformational small molecule medicines [...]

Ultragenyx Announces Plans to File for Accelerated Approval of UX111 for the Treatment of Sanfilippo Syndrome Type A (MPS IIIA)

12/06/2024 - 22:00

Agreement reached with FDA that cerebral spinal fluid (CSF) heparan sulfate (HS) can be used as a reasonable surrogate endpoint for accelerated approval Data from existing clinical studies appear sufficient for a [...]

Precipio is requesting Shareholders/Brokers vote today to avoid costly adjournment and rescheduling of Annual Shareholders Meeting

12/06/2024 - 22:00

The cost of a rescheduled shareholder meeting could reach $100,000 NEW HAVEN, Conn., June 12, 2024 (GLOBE NEWSWIRE) -- Management of specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) is requesting that [...]

Clearday Supports National Health Observances

12/06/2024 - 22:00

San Antonio, TX, June 12, 2024 (GLOBE NEWSWIRE) -- Clearday (OTC- CLRD), supports the post on May 29, 2024, from the Office of Disease Prevention and Health Promotion. Said office features monthly National Health [...]

CORRECTION-- Science 37 Surpasses Enrollment Goals, Accelerates Phase 2 Rare Disease Clinical Trial

12/06/2024 - 21:55

Science 37 Enrolls 21% of Study Participants at 11x the Speed of Traditional Research Sites Through its Virtual Site and Patient Recruitment Solutions RESEARCH TRIANGLE PARK, N.C., June 12, 2024 (GLOBE NEWSWIRE) -- In a [...]

Grant of Restricted Stock Units and Warrants to Employees in Genmab

12/06/2024 - 21:45

Company Announcement COPENHAGEN, Denmark; June 12, 2024 – Genmab A/S (Nasdaq: GMAB) announced today that the Board decided to grant 15,711 restricted stock units and 16,052 warrants to employees of the Company and the [...]

Tevogen Bio Set to Join Russell 3000® Index

12/06/2024 - 21:45

WARREN, N.J., June 12, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio Holdings Inc. (“Tevogen” or “Tevogen Bio”) (Nasdaq: TVGN ), a clinical-stage specialty immunotherapy biotech pioneer developing off-the-shelf, genetically [...]

Entourage Announces Results of 2024 Annual General Meeting of Shareholders

12/06/2024 - 21:13

TORONTO, June 12, 2024 (GLOBE NEWSWIRE) -- Entourage Health Corp. ( TSX-V:ENTG ) ( OTCQX:ETRGF ) ( FSE:4WE ) (“ Entourage ” or the “ Company ”), a Canadian producer and distributor of award-winning cannabis products, is [...]

Sanofi: Information concerning the total number of voting rights and shares – May 2024

12/06/2024 - 20:19

Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement général de l’ [...]

Sanofi: Informations relatives au nombre de droits de vote et d'actions - Mai 2024

12/06/2024 - 20:19

Informations relatives au nombre total de droits de vote et d’actions prévues par l’article L. 233-8 II du Code de commerce et l’article 223-16 du Règlement général de l’Autorité des Marchés Financiers Sanofi Société [...]

NKGen Biotech Presents Updated Phase 1 Data on SNK02 Allogeneic NK Cell Therapy for Solid Tumors at the 6th Annual Allogeneic Cell Therapies Summit 2024

12/06/2024 - 19:05

SANTA ANA, Calif., June 12, 2024 (GLOBE NEWSWIRE) -- NKGen Biotech, Inc. (Nasdaq: NKGN) (“NKGen” or the “Company”), a clinical-stage biotechnology company focused on the development and commercialization of innovative [...]

Building Awareness of Mental Health Issues in the Workplace: River Oaks Treatment Center Executive Speaks at Tampa LGBT Chamber of Commerce Luncheon

12/06/2024 - 18:54

RIVERVIEW, Fla., June 12, 2024 (GLOBE NEWSWIRE) -- River Oaks Treatment Center, a leading provider of addiction treatment services, is taking a proactive approach to raise awareness about mental health issues within the [...]

SAFE - First implantations of the Sycamore device in Switzerland

12/06/2024 - 18:00

First implantations of the Sycamore device in Switzerland Fleurieux-sur-l’Arbresle - France – June 12, 2024 at 6 p.m . Safe SA, announces the first implantations of Sycamore devices by Professor Maestretti, at the [...]

OSE Immunotherapeutics KOL Investor Webinar on the Therapeutic Landscape and Unmet Medical Needs in Non-Small Cell Lung Cancer by Dr Stephen Liu and Prof Benjamin Besse

12/06/2024 - 18:00

OSE Immunotherapeutics KOL Investor Webinar on the Therapeutic Landscape and Unmet Medical Needs in Non-Small Cell Lung Cancer by Dr Stephen Liu and Prof Benjamin Besse NANTES, France, June 12, 2024 – 6:00pm CET In this [...]

SAFE - Premières implantations du dispositif Sycamore en Suisse

12/06/2024 - 18:00

Premières implantations du dispositif Sycamore en Suisse Fleurieux-sur-l’Arbresle - France - le 12 juin 2024 à 18h . Safe SA, annonce les premières implantations de dispositifs Sycamore par le Professeur Maestretti, à l [...]